Finance

Time-tested dividend stocks are the perfect place to put your money to work if volatility picks up.

This company could become a leader in a market dominated by an outdated fee structure.

It’s possible to buy and hold for the long term and still fulfill your desire for action.

Because it’s possible to both be right and lose money.

Beyond its lofty price tag, there are other impediments to big sales of aducanamab that the market largely ignored this week.

It’s only a matter of time before the “people’s currency” comes crashing back to Earth.

Now the question is: Can your investment grow from here?

There’s a lot to like with this Buffett stock.

They’re beaten down. Short-sellers have piled on. In other words, they’re ideal meme stocks.

Bargains abound for long-term investors.

Don’t let these blunders wreck your senior years.

Buying these great companies during a big correction can make you rich.

Alzheimer’s disease patients who take Aduhelm will need a lot of diagnostic scans, too. Imaging leader RadNet stands to benefit.

Because while you canʻt teach funny, you can impart some solid investing advice this Fatherʻs Day.

Delays in FDA approval for Incyte could spell good news for Sanofi.

One of these agreements could be more important than the other.

Investors have many ways to play the renewable energy megatrend.

One is Biogen’s partner. The other is a potential rival.

Why this company is so well-positioned to thrive.

NVIDIA could become the biggest company in the world.